Kintu K, Malaba T, Nakibuka J, et al. RCT of Dolutegravir vs Efavirenz-based therapy initiated in late pregnancy: DOLPHIN-2. CROI 2019, abstract 40-LB.
EASL International Liver Congress (ILC) 2022: virale hepatitis in de spotlights
jul 2022 | Hepatitis, Vaccinatie